Literature DB >> 7365351

The effect of modified limb electrode positions on electrocardiographic wave amplitudes.

P M Rautaharju, R J Prineas, R S Crow, D Seale, C Furberg.   

Abstract

Mofidied limb electrode positions are often used in studies which require the recording of rest and exercise ECGs, whereby the arm electrodes are placed at the infraclavicular fossae and the left lef electrode on the left lower abdomen. The effect of the modified limb electrode positions on electrocardiographic waveforms was investigated in 68 supine adult male subjects at rest. The modification produced profound amplitude and waveform changes in the frontal plane ECG leads. The QRS axis shifted on the average by 16 degrees towards a more vertical position with considerable individual variation. Concomitant with the QRS axis shift, the R wave amplitude decreased in leads I and a VL and increased in leads II, III, and aVF. The S wave amplitude increased in leads III and aVF and decreased in lead III. The P and T wave amplitude changes were in a direction similar to those observed for the R waves: a reduction of the amplitude in aVL and an increase in II, III and aFV. Of importance to exercise ECG interpretation are the ST segment waveform changes: The ST slope decreased in aVL and increased in leads II, III and aVF. Waveform changes in the chest leads caused by the modification were less important although statistically significant. These systematic changes in recorded ECG waveforms arise from changes directions and strength of the lead vectors of the six frontal plane leads. Large inter-individual variations in the magnitude of the changes produced by modification of the limb electrode positions prevent effective systematic correction of the distortions by means of a universal lead transformation.

Mesh:

Year:  1980        PMID: 7365351     DOI: 10.1016/s0022-0736(80)80040-9

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  8 in total

1.  Heart monitoring garments using textile electrodes for healthcare applications.

Authors:  Hyun-Seung Cho; Su-Min Koo; Joohyeon Lee; Hakyung Cho; Da-Hye Kang; Ha-Young Song; Jeong-Whan Lee; Kang-Hwi Lee; Young-Jae Lee
Journal:  J Med Syst       Date:  2009-08-11       Impact factor: 4.460

2.  Modified electrode placement must be recorded when performing 12-lead electrocardiograms.

Authors:  N I Jowett; A M Turner; A Cole; P A Jones
Journal:  Postgrad Med J       Date:  2005-02       Impact factor: 2.401

3.  Abnormal Changes of a 12-Lead Electrocardiogram in Male Patients with Left Primary Spontaneous Pneumothorax.

Authors:  Shih-Chung Huang; Gen-Min Lin; Yi-Hwei Li; Chin-Sheng Lin; Hung-Wen Kao; Chih-Lu Han
Journal:  Acta Cardiol Sin       Date:  2014-03       Impact factor: 2.672

4.  ECG Localization Method Based on Volume Conductor Model and Kalman Filtering.

Authors:  Yuki Nakano; Essam A Rashed; Tatsuhito Nakane; Ilkka Laakso; Akimasa Hirata
Journal:  Sensors (Basel)       Date:  2021-06-22       Impact factor: 3.576

5.  The effect of body posture on cognitive performance: a question of sleep quality.

Authors:  Markus Muehlhan; Michael Marxen; Julia Landsiedel; Hagen Malberg; Sebastian Zaunseder
Journal:  Front Hum Neurosci       Date:  2014-03-27       Impact factor: 3.169

6.  True unipolar ECG machine for Wilson Central Terminal measurements.

Authors:  Gaetano D Gargiulo
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

7.  Normal limits of ECG measurements related to atrial activity using a modified limb lead system.

Authors:  Jayaraman Sivaraman; Gandhi Uma; Sangareddi Venkatesan; Mangalanathan Umapathy; Vella Elumalai Dhandapani
Journal:  Anatol J Cardiol       Date:  2014-02-26       Impact factor: 1.596

8.  Modified limb lead ECG system effects on electrocardiographic wave amplitudes and frontal plane axis in sinus rhythm subjects.

Authors:  Sivaraman Jayaraman; Venkatesan Sangareddi; R Periyasamy; Justin Joseph; Ravi Marimuthu Shanmugam
Journal:  Anatol J Cardiol       Date:  2016-06-29       Impact factor: 1.596

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.